What You Ought to Know:
– OpenEvidence, probably the most broadly used medical search and AI application amongst verified U.S. clinicians raises $210M in Sequence B funding spherical, valuing the corporate at $3.5 billion. The spherical was co-led by Google Ventures and Kleiner Perkins, with follow-on funding from Sequence A frontrunner Sequoia Capital, and extra participation from Coatue, Conviction, and Thrive. OpenEvidence has now raised over $300M since its founding.
– OpenEvidence is quickly reworking how frontline healthcare suppliers entry, consider, and apply the world’s medical data, serving to clinicians make high-stakes medical selections on the level of care.
Fixing Data Overload with Actual-Time Proof
Clinicians are overwhelmed by data overload, with the quantity of medical analysis doubling each 5 years. Conventional medical proof databases are sluggish, fragmented, and require in depth handbook looking, pulling physicians away from affected person care.
OpenEvidence addresses this by permitting clinicians to “search as soon as, skip the scavenger hunt, and floor the science in seconds”. By way of strategic content material partnerships with establishments just like the American Medical Affiliation (JAMA) and The New England Journal of Drugs, OpenEvidence supplies point-of-care solutions grounded within the newest analysis, full with references and follow-up options. OpenEvidence’s HIPAA-compliant platform quickly synthesizes medical analysis, enabling quicker, extra evidence-based selections and improved affected person outcomes by lowering the lag between new proof and bedside software.
Launching DeepConsult™: The First AI Agent for Physicians
Along with the funding announcement, OpenEvidence introduced the huge launch of OpenEvidence DeepConsult™, the primary AI agent purpose-built for physicians. DeepConsult supplies each doctor with a private, non-public group of PhD-level, medically-specialized AI brokers able to conducting superior medical analysis autonomously.
These DeepConsult brokers use superior reasoning fashions to investigate and cross-reference a whole lot of peer-reviewed medical research in parallel, surfacing not simply direct solutions but additionally novel, cross-cutting connections that may in any other case go unnoticed. This leads to an evidence-based synthesis—an integrative, interdisciplinary understanding distilled from a whole lot of research that may sometimes take a human researcher months to supply for a single medical subject.
Whereas OpenEvidence’s core search product focuses on pace (5–10 second solutions), DeepConsult addresses a special use case: offering complete analysis reviews for complicated questions when physicians have extra time, comparable to throughout a lunch break. This marks a brand new period of medical productiveness with tireless, agentic assistants.
Regardless of DeepConsult runs requiring over 100 occasions the compute and price of a typical search, OpenEvidence is providing it completely free to all verified U.S. clinicians, no matter their establishment or office, underscoring its mission to help physicians on the level of care.
Progress and Scientific Adoption
OpenEvidence is actively used throughout greater than 10,000 hospitals and medical facilities nationwide and by over 40% of physicians in the USA who log in each day. The platform continues to develop by over 65,000 new verified U.S. clinician registrations every month.
The corporate has seen exponential development: in July 2024, OpenEvidence supported roughly 358,000 logged-in, verified U.S. doctor consultations in a single month. One yr later, OpenEvidence now handles that many consultations every workday, supporting over 8,500,000 medical consultations by logged-in, verified U.S. physicians monthly—a 2,000%+ year-over-year development price. Greater than 100 million Individuals this yr will probably be handled by a health care provider who used OpenEvidence.
Growth Plans
OpenEvidence, based by Harvard- and MIT-trained PhDs Daniel Nadler and Zachary Ziegler, will use the brand new funding to increase strategic content material partnerships that improve its library of superior medical data. Daniel Nadler, founding father of Kensho (acquired by S&P International for $700 million in 2018), was additionally named to the TIME100 Well being record of the 100 Most Influential Folks in international well being in 2025. Robert M. Wachter, MD, Chair of Drugs at UCSF, lauded the partnership with the American Medical Affiliation as a big step in direction of fulfilling the promise of trusted, evidence-based medical resolution help.
